Cargando…
P53 rs1042522 and CD95 rs1800682 genetic variations in HCV-4a response to antiviral therapy
Current estimates indicate that the hepatitis C (HCV) is the leading cause of mortality around the world, with infection rates steadily increasing in Egypt. The dual therapy for this silent epidemic with pegylated-interferon-α2b/ribavirin has markedly improved the success rates in genotype-4 patient...
Autores principales: | Abd-Rabou, Ahmed A., Eskander, Emad F., Mohamed, Mervat S., Yahya, Shaymaa M.M., Sherbini, Ashraf El, Shaker, Olfat G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6150111/ https://www.ncbi.nlm.nih.gov/pubmed/30258864 http://dx.doi.org/10.1016/j.gendis.2015.02.004 |
Ejemplares similares
-
MON-519 In Silico Analysis of rs1042522 and rs1042522 Polymorphic Variants of TP53 Gene
por: Bó, Izabela Dal, et al.
Publicado: (2020) -
TP53 rs1042522 polymorphism and early-onset breast cancer
por: Icen-Taskin, Irmak, et al.
Publicado: (2020) -
Distinct role of the Fas rs1800682 and FasL rs763110 polymorphisms in determining the risk of breast cancer among Han Chinese females
por: Wang, Meng, et al.
Publicado: (2016) -
The Functional TP53 rs1042522 and MDM4 rs4245739 Genetic Variants Contribute to Non-Hodgkin Lymphoma Risk
por: Fan, Chuanbo, et al.
Publicado: (2014) -
Study of Association between Pre-Senile Cataracts and the Polymorphisms rs2228000 in XPC and rs1042522 in p53 in Spanish Population
por: López Valverde, Gloria, et al.
Publicado: (2016)